During a press conference on Wednesday, chief medical advisor with the regulatory branch of Health Canada Dr. Supriya Sharma stressed that the approval of the Pfizer coronavirus vaccine came after a rigorous review of clinical trial data, and emphasized that the health agency authorized the drug after finding no serious safety concerns and Canadians should “absolutely” feel comfortable getting it.
Read more on globalnews.ca